Cargando…
Next-generation sequencing of adrenocortical carcinoma reveals new routes to targeted therapies
AIMS: Adrenocortical carcinoma (ACC) carries a poor prognosis and current systemic cytotoxic therapies result in only modest improvement in overall survival. In this retrospective study, we performed a comprehensive genomic profiling of 29 consecutive ACC samples to identify potential targets of the...
Autores principales: | Ross, J S, Wang, K, Rand, J V, Gay, L, Presta, M J, Sheehan, C E, Ali, S M, Elvin, J A, Labrecque, E, Hiemstra, C, Buell, J, Otto, G A, Yelensky, R, Lipson, D, Morosini, D, Chmielecki, J, Miller, V A, Stephens, P J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4215283/ https://www.ncbi.nlm.nih.gov/pubmed/25078331 http://dx.doi.org/10.1136/jclinpath-2014-202514 |
Ejemplares similares
-
Next-generation sequencing reveals frequent consistent genomic alterations in small cell undifferentiated lung cancer
por: Ross, J S, et al.
Publicado: (2014) -
A metastatic colon adenocarcinoma harboring BRAF V600E has a durable major response to dabrafenib/trametinib and chemotherapy
por: Williams, Casey B, et al.
Publicado: (2015) -
Durable clinical benefit to trastuzumab and chemotherapy in a patient with metastatic colon adenocarcinoma harboring ERBB2 amplification
por: Disel, Umut, et al.
Publicado: (2015) -
The distribution of BRAF gene fusions in solid tumors and response to targeted therapy
por: Ross, Jeffrey S., et al.
Publicado: (2016) -
Comprehensive genomic profiling identifies a novel TNKS2–PDGFRA fusion that defines a myeloid neoplasm with eosinophilia that responded dramatically to imatinib therapy
por: Chalmers, Z R, et al.
Publicado: (2015)